Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.504
-0.096 (-6.00%)
Oct 22, 2025, 3:31 PM EDT - Market open
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $10.74 million as of October 22, 2025. Its market cap has increased by 17.59% in one year.
Market Cap
10.74M
Enterprise Value
12.08M
1-Year Change
17.59%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $10.74M, a decrease of -97.42%. That is a compound annual growth rate of -41.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 11.43M | -27.22% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | 84.01M | -81.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.01B |
| Johnson & Johnson | 464.76B |
| AbbVie | 409.51B |
| UnitedHealth Group | 328.84B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 224.03B |